How the latest minimally invasive techniques can be used to treat BPH, the most common urological condition for men aged 50 and older.
CPD EDUCATION
Now available on-demand.
This education has been developed by Praxhub and the Interventional Radiology Society of Australasia (IRSA).
Event countdown
Benign prostatic hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland that affects men as they age. It is the most common urological condition in men over 50, with up to 80% of men experiencing symptoms by the age of 80. In Australia, around 1 in 5 men aged 50 and over have been diagnosed with BPH. The most common symptoms of BPH are difficulty urinating, a weak urine stream, and frequent urination, especially at night. There is no cure for BPH, but there are treatments available to help manage the symptoms.
Minimally invasive techniques are used to treat BPH when medications are not effective or when the patient prefers a less invasive option, yet awareness of these options may be mixed in general practice. GPs will be presented with a short overview on the established treatment options in addition to prostate artery embolization (PAE) which may be suitable for patients for whom other techniques are not appropriate. Within tertiary care, interventional radiologists are well positioned to offer these options to GPs and their patients.
The education provides the GP with an overview of when to consider minimally invasive treatment options, what these options are and how to access them. By increasing GP awareness of these treatment options, patients with BPH will have greater choice in how they wish to manage their condition.
5
Demonstrate a framework for assessing menopausal symptom severity and for providing advice to women on options for optimal management.
1
Describe minimally invasive treatment options for patients with severe Benign Prostatic Hyperplasia who are unsuitable for TURP.
3
Summarise current evidence regarding the efficacy and safety of MHT and non-hormonal therapies for menopause symptoms.
2
Outline a clinical approach to selection of patients who would be suitable for prostatic arterial emobolisation.
4
Praxhub is an RACGP accredited provider under the RACGP CPD Program.
Activity ID: 31337
Praxhub is a Certified Learning Provider under the CPD Home 2023-24 CPD Program.
This medical education activity has been approved for 1 CPD hour with:
Activity ID: 604689
Activity ID: 703
Please enter your details to attend.
Once completed, please check your email for reminders.
* indicates required field
© Praxhub 2024, all rights reserved.
Australian Daylight Standard Time: 7:30pm
Melbourne/Canberra/Sydney/Hobart (GMT+11)
Norfolk Island Daylight Time: 8:30pm
(GMT+12)
Australian Eastern Standard Time: 6:30pm
Brisbane (GMT+10)
Australian Central Daylight Time: 7:00pm
Adelaide (GMT+10.30)
Australian Western Standard Time: 4:30pm
Perth (GMT+8)
Christmas Island Time: 3:30pm
(GMT+7)